Department of Pathology and Laboratory Medicine, University of Cincinnati College of Medicine, 2120 E. Galbraith Rd., Cincinnati, OH 45237, USA.
FASEB J. 2010 Jul;24(7):2516-24. doi: 10.1096/fj.09-144436. Epub 2010 Mar 9.
Decrease in fat catabolic rate on consuming a high-fat diet contributes to diet-induced obesity. This study used group 1B phospholipase A(2) (Pla2g1b)-deficient mice, which are resistant to hyperglycemia, to test the hypothesis that Pla2g1b and its lipolytic product lysophospholipid suppress hepatic fat utilization and energy metabolism in promoting diet-induced obesity. The metabolic consequences of hypercaloric diet, including body weight gain, energy expenditure, and fatty acid oxidation, were compared between Pla2g1b(+/+) and Pla2g1b(-/-) mice. The Pla2g1b(-/-) mice displayed normal energy balance when fed chow, but were resistant to obesity when challenged with a hypercaloric diet. Obesity resistance in Pla2g1b(-/-) mice is due to their ability to maintain elevated energy expenditure and core body temperature when subjected to hypercaloric diet, which was not observed in Pla2g1b(+/+) mice. The Pla2g1b(-/-) mice also displayed increased postprandial hepatic fat utilization due to increased expression of peroxisome proliferator-activated receptor (PPAR)-alpha, PPAR-delta, PPAR-gamma, cd36/Fat, and Ucp2, which coincided with reduced postprandial plasma lysophospholipid levels. Lysophospholipids produced by Pla2g1b hydrolysis suppress hepatic fat utilization and down-regulate energy expenditure, thereby preventing metabolically beneficial adaptation to a high-fat diet exposure in promoting diet-induced obesity and type 2 diabetes.
进食高脂肪饮食会降低脂肪分解率,从而导致饮食诱导的肥胖。本研究使用对高血糖有抗性的 1B 组磷脂酶 A2(Pla2g1b)缺陷型小鼠来验证假设,即 Pla2g1b 及其水解产物溶血磷脂会抑制肝内脂肪利用和能量代谢,从而促进饮食诱导的肥胖和 2 型糖尿病的发生。比较 Pla2g1b(+/+)和 Pla2g1b(-/-)小鼠在高脂饮食下的代谢后果,包括体重增加、能量消耗和脂肪酸氧化。在正常饮食条件下,Pla2g1b(-/-)小鼠的能量平衡正常,但在高脂饮食的挑战下,它们对肥胖具有抗性。Pla2g1b(-/-)小鼠对肥胖的抗性归因于它们在接受高脂饮食时维持高能量消耗和核心体温的能力,而 Pla2g1b(+/+)小鼠则没有观察到这种能力。Pla2g1b(-/-)小鼠餐后肝内脂肪利用增加,这与餐后血浆溶血磷脂水平降低有关,可能是由于过氧化物酶体增殖物激活受体 (PPAR)-α、PPAR-δ、PPAR-γ、cd36/Fat 和 Ucp2 的表达增加所致。Pla2g1b 水解产生的溶血磷脂会抑制肝内脂肪利用并下调能量消耗,从而防止代谢上有益的适应高脂饮食暴露,促进饮食诱导的肥胖和 2 型糖尿病的发生。